RNA Targeting Small Molecules Therapeutics Global Market Report 2024

Global RNA Targeting Small Molecules Therapeutics Market Report 2024

RNA Targeting Small Molecules Therapeutics Global Market Report 2024 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings), By Therapeutic Indication (Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications), By Application (Drug Discovery, Oncology Research, Disease Identification), By End User (Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Name: RNA Targeting Small Molecules Therapeutics Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

RNA Targeting Small Molecules Therapeutics Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

RNA Targeting Small Molecules Therapeutics Global Market Report 2024

Proud Members Of

RNA Targeting Small Molecules Therapeutics Market Definition

RNA-targeting small molecule therapeutics refers to small molecule therapeutics that precisely interact with RNA molecules to modify their function or stability. These treatments treat diseases by employing small-molecule drugs to target disease-causing RNA molecules.

The main offerings of RNA targeting small molecule therapeutics are mRNA (messenger ribonucleic acid) translation modulators, RNA (ribonucleic acid) splicing modification, direct RNA (ribonucleic acid) targeting, and others. mRNA translation modulators are substances or factors that influence the process of protein synthesis by altering the efficiency or rate of mRNA translation. These are indicated for the treatment of lung fibrosis, cancer, neurodegenerative diseases, autoimmune, inflammatory, and others, with applications including drug discovery, oncology research, and disease identification performed by hospitals, research laboratories, pharmaceutical and biotechnology companies, and others.

RNA Targeting Small Molecules Therapeutics Market Segmentation

The rna targeting small molecules therapeutics market covered in this report is segmented –

1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings

2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications

3) By Application: Drug Discovery, Oncology Research, Disease Identification

4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users

Global RNA Targeting Small Molecules Therapeutics Market Size 2023 to 2028: Graph

RNA Targeting Small Molecules Therapeutics Market Size 2024 And Growth Rate

The rna targeting small molecules therapeutics market size has grown exponentially in recent years. It will grow from $1.06 billion in 2023 to $1.45 billion in 2024 at a compound annual growth rate (CAGR) of 37.0%. The growth in the historic period can be attributed to drug discovery and development, rising prevalence of rna-related diseases, government and private funding, pharmaceutical industry interest, rna therapeutics success stories.

RNA Targeting Small Molecules Therapeutics Market Growth Forecast

The rna targeting small molecules therapeutics market size is expected to see exponential growth in the next few years. It will grow to $5.09 billion in 2028 at a compound annual growth rate (CAGR) of 36.9%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, rise in rna biomarker identification, expanding rna target spectrum, increasing funding and investments, application in rare diseases. Major trends in the forecast period include advancements in screening technologies, antisense oligonucleotides dominance, small molecule rna binders, rna therapeutics in neurological disorders, gene editing with crispr-cas9.

Book your 30 minutes free consultation with our research experts

RNA Targeting Small Molecules Therapeutics Market Driver: Surge In Cancer Cases Fuels Expansion Of The Rna-Targeting Small Molecule Therapeutics Market

The increasing number of cancer cases is expected to propel the growth of the RNA-targeting small molecule therapeutics market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Cancer is treated with RNA-targeting small molecules created and investigated to target RNA molecules associated with cancer selectively. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. It is about 1,670 fatalities each day. Therefore, the increasing number of cancer cases is driving the growth of the RNA-targeting small molecule therapeutics market.

RNA Targeting Small Molecules Therapeutics Market Driver: Growing Genetic Disorder Incidence Fuels Expansion Of The Rna-Targeting Small Molecule Therapeutics Market

The rising incidence of genetic disorders is expected to boost the growth of the RNA-targeting small-molecule therapeutics market going forward. Genetic disorders are conditions caused by abnormalities or mutations in an individual's genetic material, such as DNA or chromosomes. RNA-targeting small-molecule therapeutics are an exciting emerging field with immense potential for treating genetic disorders. Some genetic disorders involve toxic expansions of repeated RNA sequences. Small molecules can stabilize or destabilize these expansions, potentially mitigating their harmful effects. For instance, in June 2023, according to a report published by the Lancet, a UK-based medical journal, globally, the population of individuals with sickle cell disease witnessed a 41.4% surge to reach 7.74 million in 2021, with a projected 34,400 cause-specific deaths and a significantly higher total mortality burden of 376,000. Among children under 5 years, there were 81,100 deaths, elevating the overall sickle cell disease mortality ranking to 12th globally. Therefore, the rising incidence of genetic disorders is driving the growth of the RNA-targeting small-molecule therapeutic market.

Global RNA Targeting Small Molecules Therapeutics Market Major Players

Major companies operating in the rna targeting small molecules therapeutics market report are F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Janssen Pharmaceuticals, Celgene Corporation, Vertex Pharmaceuticals, Servier laboratories, Genentech Inc., PTC Therapeutics Inc., Arrakis Therapeutics, Anima Biotech Inc., Skyhawk Therapeutics Inc., Remix Therapeutics, Abivax SA, 858 Therapeutics, Eloxx Pharmaceuticals Inc., STORM Therapeutics Ltd., Accent Therapeutics Inc., eFFECTOR Therapeutics Inc., EPICS Therapeutics, Expansion Therapeutics Inc., Inspirna Inc., MiNA Therapeutics Ltd., Ribometrix Inc., AC Immune SA, Redona Therapeutics.

Global RNA Targeting Small Molecules Therapeutics Market Trend: Strategic Partnerships Drive Innovation In The Rna-Targeting Small Molecule Therapeutics Market

Strategic partnerships are a key trend gaining popularity in the RNA-targeting small molecule therapeutics market. Major companies operating in the RNA-targeting small molecule therapeutics market are undergoing partnerships to develop a new relationship in which two or more organizations develop innovative products. For instance, in June 2022, Otsuka Pharmaceutical Co. Ltd., a Japan-based pharmaceutical manufacturing company, collaborated with xFOREST Therapeutics Co. Ltd., a Japan-based developer of drug discovery platforms. With this partnership, xFOREST will offer Otsuka with its Forest technology to advance systemic small-molecule drug discovery research focusing on RNA structures. Furthermore, in March 2021, Evotec SE, a Germany-based drug discovery and development company, entered a strategic alliance with Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company. Both companies aim to discover and develop RNA-targeting small molecules with this alliance.

Global RNA Targeting Small Molecules Therapeutics Market Trend: The Growing Significance Of Rna-Targeting Small Molecule Therapeutics In Addressing Rising Global Infectious Diseases

The rising infectious diseases worldwide are expected to boost the growth of the RNA-targeting small molecule therapeutics market. Infectious diseases refer to disorders caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. RNA-targeting small molecules are emerging as a promising new approach to combatting infectious diseases. These small molecules, typically less than 500 daltons, bind to specific structures within RNA molecules, thereby disrupting their function and hindering the pathogen's replication or virulence. For instance, according to the Office for National Statistics, a UK-based recognized national statistics institute, in England at the end of the week ending December 9, 2022, the infection rate climbed for people aged 35 to 69 years and increased for those in school years 12 to 24 years. In the week ending December 18, 2022, the total hospital admission rate for patients with confirmed COVID-19 in England increased to 9.56 per 100,000 individuals. The admission rate to intensive care units (ICUs) and high dependency units (HDUs) climbed to 0.29 per 100,000 inhabitants. Therefore, the rising infectious diseases worldwide are driving the growth of the RNA-targeting small molecule therapeutics market.

RNA Targeting Small Molecules Therapeutics Market Merger And Acquisition: Ribometrix And Genentech Collaborate On Advancing Rna-Targeted Therapeutic Small Molecules

In January 2021, Ribometrix, Inc., a US-based drug discovery company, collaborated with Genentech Inc. to find and create RNA-targeted therapeutic small molecules. In this collaboration, Genentech and Ribometrix will develop programs, development, and commercialization within Genentech's purview to see and improve small-molecule drugs that modify RNA function by focusing on three-dimensional (3D) RNA structures. Genentech Inc. is a US-based biotechnology research company.

Regional Outlook For The Global RNA Targeting Small Molecules Therapeutics Market

North America was the largest region in the RNA targeting small molecules therapeutics market in 2023. The regions covered in the rna targeting small molecules therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rna targeting small molecules therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The RNA-targeting small molecule therapeutics market consists of sales of nusinersen, inotersen, givosiran, and patisiran. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The RNA targeting small molecules therapeutics research report is one of a series of new reports from The Business Research Company that provides RNA targeting small molecules therapeutics market statistics, including the RNA targeting small molecules therapeutics industry's global market size, regional shares, competitors with RNA targeting small molecules therapeutics market share, detailed RNA targeting small molecules therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the RNA targeting small molecules therapeutics industry. This RNA-targeting small molecules therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

RNA Targeting Small Molecules Therapeutics Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$1.45 billion
Revenue Forecast In 2033	$5.09 billion
Growth Rate	CAGR of 36.9% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings 2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications 3) By Application: Drug Discovery, Oncology Research, Disease Identification 4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche Ltd.; Bayer AG; Sanofi S.A.; AstraZeneca plc; Eli Lilly and Company; Amgen Inc.; Janssen Pharmaceuticals; Celgene Corporation; Vertex Pharmaceuticals; Servier laboratories; Genentech Inc.; PTC Therapeutics Inc.; Arrakis Therapeutics; Anima Biotech Inc.; Skyhawk Therapeutics Inc.; Remix Therapeutics; Abivax SA; 858 Therapeutics; Eloxx Pharmaceuticals Inc.; STORM Therapeutics Ltd.; Accent Therapeutics Inc.; eFFECTOR Therapeutics Inc.; EPICS Therapeutics; Expansion Therapeutics Inc.; Inspirna Inc.; MiNA Therapeutics Ltd.; Ribometrix Inc.; AC Immune SA; Redona Therapeutics.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. RNA Targeting Small Molecules Therapeutics Market Characteristics

3. RNA Targeting Small Molecules Therapeutics Market Trends And Strategies

4. RNA Targeting Small Molecules Therapeutics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global RNA Targeting Small Molecules Therapeutics Market Size and Growth

5.1. Global RNA Targeting Small Molecules Therapeutics Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global RNA Targeting Small Molecules Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global RNA Targeting Small Molecules Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. RNA Targeting Small Molecules Therapeutics Market Segmentation

6.1. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

mRNA (Messenger Ribonucleic Acid) Translation Modulators

RNA (Ribonucleic Acid) Splicing Modification

Direct RNA (Ribonucleic Acid) Targeting

Other Offerings

6.2. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Lung Fibrosis

Cancer

Neurodegenerative Diseases

Autoimmune

Inflammatory

Other Therapeutic Indications

6.3. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Drug Discovery

Oncology Research

Disease Identification

6.4. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Research Laboratories

Pharmaceutical And Biotechnology Companies

Other End-Users

7. RNA Targeting Small Molecules Therapeutics Market Regional And Country Analysis

7.1. Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market

8.1. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China RNA Targeting Small Molecules Therapeutics Market

9.1. China RNA Targeting Small Molecules Therapeutics Market Overview

9.2. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India RNA Targeting Small Molecules Therapeutics Market

10.1. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan RNA Targeting Small Molecules Therapeutics Market

11.1. Japan RNA Targeting Small Molecules Therapeutics Market Overview

11.2. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia RNA Targeting Small Molecules Therapeutics Market

12.1. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia RNA Targeting Small Molecules Therapeutics Market

13.1. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea RNA Targeting Small Molecules Therapeutics Market

14.1. South Korea RNA Targeting Small Molecules Therapeutics Market Overview

14.2. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe RNA Targeting Small Molecules Therapeutics Market

15.1. Western Europe RNA Targeting Small Molecules Therapeutics Market Overview

15.2. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK RNA Targeting Small Molecules Therapeutics Market

16.1. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany RNA Targeting Small Molecules Therapeutics Market

17.1. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France RNA Targeting Small Molecules Therapeutics Market

18.5. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy RNA Targeting Small Molecules Therapeutics Market

19.9. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain RNA Targeting Small Molecules Therapeutics Market

20.13. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe RNA Targeting Small Molecules Therapeutics Market

21.1. Eastern Europe RNA Targeting Small Molecules Therapeutics Market Overview

21.2. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia RNA Targeting Small Molecules Therapeutics Market

22.1. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America RNA Targeting Small Molecules Therapeutics Market

23.1. North America RNA Targeting Small Molecules Therapeutics Market Overview

23.2. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA RNA Targeting Small Molecules Therapeutics Market

24.1. USA RNA Targeting Small Molecules Therapeutics Market Overview

24.2. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada RNA Targeting Small Molecules Therapeutics Market

25.1. Canada RNA Targeting Small Molecules Therapeutics Market Overview

25.2. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America RNA Targeting Small Molecules Therapeutics Market

26.1. South America RNA Targeting Small Molecules Therapeutics Market Overview

26.2. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil RNA Targeting Small Molecules Therapeutics Market

27.1. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East RNA Targeting Small Molecules Therapeutics Market

28.1. Middle East RNA Targeting Small Molecules Therapeutics Market Overview

28.2. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa RNA Targeting Small Molecules Therapeutics Market

29.1. Africa RNA Targeting Small Molecules Therapeutics Market Overview

29.2. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. RNA Targeting Small Molecules Therapeutics Market Competitive Landscape And Company Profiles

30.1. RNA Targeting Small Molecules Therapeutics Market Competitive Landscape

30.2. RNA Targeting Small Molecules Therapeutics Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Bayer AG

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Sanofi S.A.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. AstraZeneca plc

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Eli Lilly and Company

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. RNA Targeting Small Molecules Therapeutics Market Other Major And Innovative Companies

31.1. Amgen Inc.

31.2. Janssen Pharmaceuticals

31.3. Celgene Corporation

31.4. Vertex Pharmaceuticals

31.5. Servier laboratories

31.6. Genentech Inc.

31.7. PTC Therapeutics Inc.

31.8. Arrakis Therapeutics

31.9. Anima Biotech Inc.

31.10. Skyhawk Therapeutics Inc.

31.11. Remix Therapeutics

31.12. Abivax SA

31.13. 858 Therapeutics

31.14. Eloxx Pharmaceuticals Inc.

31.15. STORM Therapeutics Ltd.

32. Global RNA Targeting Small Molecules Therapeutics Market Competitive Benchmarking

33. Global RNA Targeting Small Molecules Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The RNA Targeting Small Molecules Therapeutics Market

35. RNA Targeting Small Molecules Therapeutics Market Future Outlook and Potential Analysis

35.1 RNA Targeting Small Molecules Therapeutics Market In 2028 - Countries Offering Most New Opportunities

35.2 RNA Targeting Small Molecules Therapeutics Market In 2028 - Segments Offering Most New Opportunities

35.3 RNA Targeting Small Molecules Therapeutics Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: F. Hoffmann-La Roche Ltd. Financial Performance

Table 76: Bayer AG Financial Performance

Table 77: Sanofi S.A. Financial Performance

Table 78: AstraZeneca plc Financial Performance

Table 79: Eli Lilly and Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 76: Bayer AG Financial Performance

Figure 77: Sanofi S.A. Financial Performance

Figure 78: AstraZeneca plc Financial Performance

Figure 79: Eli Lilly and Company Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

Wired Charging Global Market Report 2024 – By Type (Type C, Micro USB, Lightning, Other Types), By Charging Type (Standard, Fast), By Sales Channel (Online, Offline), By Application (Automotive, Consumer Electronics, Smartphones, Tablets, Healthcare Devices, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Rehabilitation Robotics Global Market Report 2024 – By Type (Exoskeleton Robots, Therapeutic Robots, Assistive Robots, Prosthetic Robots), By Patient Type (Adult, Pediatrics ), By Part (Lower Extremity, Upper Extremity), By Application (Gait Therapy, Limb Mobility), By End User (Rehabilitation Centers, Hospitals) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Offshore Wind Global Market Report 2024 – By Component (Turbines, Electrical Infrastructure, Substructure, Other Components), By Location (Shallow Water, Transitional Water, Deep Water), By Capacity (Up to 3MW, 3MW to 5MW, Above 5MW), By Application (Electric Power, Oil and Gas, Aviation, Transport, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Enterprise Risk Management Global Market Report 2024 – By Deployment (Cloud, On-Premises), By Component (Hardware, Software, Services), By Industry Vertical (BFSI, IT and Telecom, Retail, Healthcare, Energy and Utilities, Manufacturing, Government and Defense) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Material Handling Global Market Report 2024 – By Type (Automated Guided Vehicles, Automated Storage And Retrieval Systems, Trucks And Lifts, Cranes, Pallet Racking, Conveying Systems, Hoists, Other Types), By Operations (Assembly, Distribution, Transportation, Other Operations), By End User (Food & Beverages, Automotive, Construction, Consumer Goods & Electronic, Pharmaceuticals, E-Commerce, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Decorative Lighting Global Market Report 2024 – By Product (Ceiling, Wall-Mounted, Other Products), By Light Source (Light Emitting Diode (LED), Fluorescent, Incandescent, Other Light Sources), By Distribution Channel (Offline, Online), By End Use (Commercial, Household) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Machinery Global Market Report 2024 – By Type (Automatic, Semi-Automatic), By Capacity (Small, Medium, Large), By Application (Automotive, Precision Engineering, Transport, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the RNA targeting small molecules therapeutics market?

How will the RNA targeting small molecules therapeutics market drivers and restraints affect the RNA targeting small molecules therapeutics market dynamics? What forces will shape the RNA targeting small molecules therapeutics industry going forward?

The RNA targeting small molecules therapeutics market major growth driver - Surge In Cancer Cases Fuels Expansion Of The Rna-Targeting Small Molecule Therapeutics Market. For further insights on the RNA targeting small molecules therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the RNA targeting small molecules therapeutics market?

The RNA targeting small molecules therapeutics market size has grown exponentially in recent years. It will grow from $1.06 billion in 2023 to $1.45 billion in 2024 at a compound annual growth rate (CAGR) of 37.0%. The growth in the historic period can be attributed to drug discovery and development, rising prevalence of rna-related diseases, government and private funding, pharmaceutical industry interest, rna therapeutics success stories. The RNA targeting small molecules therapeutics market size is expected to see exponential growth in the next few years. It will grow to $5.09 billion in 2028 at a compound annual growth rate (CAGR) of 36.9%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, rise in rna biomarker identification, expanding rna target spectrum, increasing funding and investments, application in rare diseases. Major trends in the forecast period include advancements in screening technologies, antisense oligonucleotides dominance, small molecule rna binders, rna therapeutics in neurological disorders, gene editing with crispr-cas9. For further insights on the RNA targeting small molecules therapeutics market, request a sample here

How is the RNA targeting small molecules therapeutics market segmented?

The RNA targeting small molecules therapeutics market is segmented
1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings
2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications
3) By Application: Drug Discovery, Oncology Research, Disease Identification
4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-UsersFor further insights on the RNA targeting small molecules therapeutics market, request a sample here

Which region has the largest share of the RNA targeting small molecules therapeutics market? What are the other regions covered in the report?

North America was the largest region in the RNA targeting small molecules therapeutics market in 2023. The regions covered in the RNA targeting small molecules therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the RNA targeting small molecules therapeutics market, request a sample here.

Who are the major players in the RNA targeting small molecules therapeutics market?

Major companies operating in the RNA targeting small molecules therapeutics market report are F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Janssen Pharmaceuticals, Celgene Corporation, Vertex Pharmaceuticals, Servier laboratories, Genentech Inc., PTC Therapeutics Inc., Arrakis Therapeutics, Anima Biotech Inc., Skyhawk Therapeutics Inc., Remix Therapeutics, Abivax SA, 858 Therapeutics, Eloxx Pharmaceuticals Inc., STORM Therapeutics Ltd., Accent Therapeutics Inc., eFFECTOR Therapeutics Inc., EPICS Therapeutics, Expansion Therapeutics Inc., Inspirna Inc., MiNA Therapeutics Ltd., Ribometrix Inc., AC Immune SA, Redona Therapeutics. For further insights on the RNA targeting small molecules therapeutics market, request a sample here.

What are the key trends in the RNA targeting small molecules therapeutics market?

Major trend in the RNA targeting small molecules therapeutics market - Strategic Partnerships Drive Innovation In The Rna-Targeting Small Molecule Therapeutics Market. For further insights on the RNA targeting small molecules therapeutics market, request a sample here.

What are the major opportunities in the RNA targeting small molecules therapeutics market? What are the strategies for the RNA targeting small molecules therapeutics market?

For detailed insights on the major opportunities and strategies in the RNA targeting small molecules therapeutics market, request a sample here.

How does the RNA targeting small molecules therapeutics market relate to the overall economy and other similar markets?

For detailed insights on RNA targeting small molecules therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the RNA targeting small molecules therapeutics industry?

For detailed insights on the mergers and acquisitions in the RNA targeting small molecules therapeutics industry, request a sample here.

What are the key dynamics influencing the RNA targeting small molecules therapeutics market growth? SWOT analysis of the RNA targeting small molecules therapeutics market.

For detailed insights on the key dynamics influencing the RNA targeting small molecules therapeutics market growth and SWOT analysis of the RNA targeting small molecules therapeutics industry, request a sample here.